Heidelberg, Germany
November 29, 2004
Gentana GmbH has successfully
completed a pilot study of its gene-mapping technology with
Monsanto Company, based in St. Louis, Mo. Under the
collaboration, Monsanto evaluated Gentana's iGentifier.
Open-profiling
systems, such as Gentana's iGentifier™ technology, are helpful
tools for mapping genes when gene sequence information is
sparse.
"The life science
industries are increasingly recognizing the importance of open
gene expression profiling technologies for developing new
products," Gentana's Chief Executive Officer Jürgen Bauer,
Ph.D., said. "We are very pleased that Monsanto, as one of the
world's leading agricultural biotechnology companies, evaluated
our novel technology platform. The successful completion of this
study is a cornerstone in Gentana's development toward becoming
a leading provider for open gene expression profiling
solutions."
"iGentifier™ is a
unique technology platform for open gene expression profiling,
combining the advantages of virtually all open expression
profiling technologies that have been developed previously.
Gentana's technology is the first cost-effective solution
supporting comprehensive expression profiling studies of any
number of samples. Compared to conventional technologies,
iGentifier™ offers key advantages in terms of robustness,
reliability and sensitivity. It can detect subtle changes in
gene expression and allows even weakly expressed genes to be
studied. The iGentifier™ platform ensures transcript analysis
that exceeds the limits of microarrays. It is available as a
customer in-house solution and as a full service.
The iGentifier™
platform is attractive to scientists in the agricultural, food,
feed and pharmaceutical industries. It enables customers to
identify genes and biochemical pathways relevant to, e.g.,
plant, animal and fungal productivity, pathogenesis, resistance,
and the response to stress factors.
GENTANA
specializes in the analysis of biological processes at the
molecular level through monitoring the activity of all genes
within an organism. The company develops functional genomics
technologies and translates them into customer oriented, problem
solving solutions. With the help of these powerful analytical
methods companies throughout the Life Sciences industry can
develop superior products while shortening their product
development times. As a spin-out of
Axaron Bioscience AG GENTANA
builds upon assets and experience in the functional genomics
field, gained through serving customers for over 6 years.
|